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Abstract
Background The benefit of ischemic postconditioning (IPostC) might be the throttled inflow following cold ischemia. The 
current study investigated advantage and mechanisms of IPostC in healthy and fatty rat livers.
Methods Male SD rats received a high-fat diet to induce fatty livers. Isolated liver perfusion was performed after 24 h 
ischemia at 4 °C as well as in vivo experiments after 90 min warm ischemia. The so-called follow-up perfusions served to 
investigate the hypothesis that medium from IPostC experiments is less harmful. Lactate dehydrogenase (LDH), transami-
nases, different cytokines, and gene expressions, respectively, were measured.
Results Fatty livers showed histologically mild inflammation and moderate to severe fat storage. IPostC reduced LDH 
and  TXB2 in healthy and fatty livers and increased bile flow. LDH, TNF-α, and IL-6 levels in serum decreased after warm 
ischemia + IPostC. The gene expressions of Tnf, IL-6, Ccl2, and Ripk3 were downregulated in vivo after IPostC.
Conclusions IPostC showed protective effects after ischemia in situ and in vivo in healthy and fatty livers. Restricted cyclic 
inflow was an important mechanism and further suggested involvement of necroptosis. IPostC represents a promising and 
easy intervention to improve outcomes after transplantation.
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Abbreviations
EvG  Elastica van Gieson
HE  Hematoxylin/eosin
HFD  High-fat diet
ICAM  Intercellular adhesion molecule
IL  Interleukin
IPC  Ischemic preconditioning
IPostC  Ischemic postconditioning
IRI  Ischemia–reperfusion injury
LDH  Lactate dehydrogenase
NO  Nitric oxide
RIPK  Receptor-interacting protein kinase
SOD  Superoxide dismutase
TNF  Tumor necrosis factor
TX  Thromboxane
Introduction
Ischemia reperfusion injury (IRI) is a major issue after 
liver transplantation. The interruption of oxygenation dur-
ing ischemia leads to a narrowing of liver sinusoids with 
impaired microcirculation [1, 2] and triggers the release of 
reactive oxygen species (ROS) and inflammatory cytokines 
by activated Kupffer cells (KCs) as well as neutrophils [2, 
3]. With the start of reperfusion, new oxygen is available 
for oxidative processes, and pH-dependent proteases and 
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phosphatases are activated to continue and exacerbate liver 
damage [4]. Both ischemia and reperfusion impair organ 
function, which may cause organ failure and threaten 
patient survival after liver transplantation [5, 6].
One easy-to-apply surgical method to protect the liver 
against IRI consists of a procedure called ischemic post-
conditioning (IPostC). This strategy applies a series of 
brief periods of ischemia and reperfusion immediately 
after the ischemic period (in organ recipients), but prior 
to continuous reperfusion. Earlier experimental studies 
were performed in isolated perfused hearts and showed a 
protective effect on myocardium [7]. The first study testing 
IPostC in the liver in 2004 described a reduction in hepa-
tocellular apoptosis through the downregulation of Bcl-2 
and the inhibition of ROS by IPostC [8]. Further inves-
tigations into IPostC after ischemia showed a protective 
effect regarding liver regeneration [9] and gene expression 
profiles in liver tissue [10]. One human study showed a 
better tolerance to I/R injury on histological findings of 
grafts receiving IPostC [11].
A protective effect of IPostC was demonstrated in healthy 
livers [12, 13]. So far, there are no data on fatty livers. We 
investigated in the present study the influence of IPostC 
particularly on fatty livers to determine whether IPostC is 
able to protect healthy and fatty livers against IRI. Further-
more, we worked up a new method to investigate whether the 
dosed reperfusion is associated with reduced liver damage.
Materials and Methods
Animal Studies
Male Sprague–Dawley (SD) rats weighing 151–175 g from 
Charles River (Charles River Wiga GmbH, Sulzfeld) were 
used. The animals were treated according to the ethics cri-
teria established by the National Academy of Sciences and 
published by the National Institutes of Health, in addition 
to the legal requirements of Germany. All animal experi-
ments were approved by the local government (Regierung 
von Oberbayern, Munich) and were reported to the respon-
sible authorities.
Diet‑Induced Obesity
To induce fatty livers [14, 15], the animals received a con-
trol diet with 10% energy from fat (Altromin, Lage) for 
10 days to prepare the gastrointestinal tract for the high–fat 
diet (HFD) with 70% energy from fat (Altromin, Lage) for 
4 weeks ad libitum until perfusion.
Isolated Rat Liver Perfusion: Cold Ischemia 
and IPostC
SD rats were anesthetized with an intraperitoneal injection 
of pentobarbital (30–50 mg/kg of body weight) and intrave-
nously received heparin (2000–5000 U/kg of body weight) 
via the femoral vein. After median laparotomy, a soft cath-
eter was inserted into the portal vein and secured with two 
previously laid ligatures. The abdominal inferior vena cava 
was opened to flush out blood from the liver. After open-
ing the thorax, a soft catheter was inserted into the right 
atrium and secured with two ligatures. A ligature around 
the abdominal inferior vena cava was drawn to derive the 
medium through the atrium and to collect it. Finally, the 
common bile duct was cannulated with a catheter to deter-
mine the bile flow (in ml/min × g liver) during perfusion. 
The portal perfusion pressure (in cmH2O) was continuously 
monitored.
After stabilization for 30 min, the liver was perfused 
with 30 ml of cold HTK solution (Dr. Franz Köhler Chemie 
GmbH, Bensheim) for 1 min. Storage of the liver outside of 
the animals for 24 h at 4 °C in HTK solution was followed 
with reperfusion lasting 2 h. In control group (n = 8), only 
reperfusion was performed. In the intervention groups (each 
n = 8), two different cycles of IPostC were tested immedi-
ately following ischemia: 8 × 20 s and 4 × 60 s (Fig. 1a). 
Perfusate and bile were collected at specific time points and 
stored at − 80 °C. Samples of the livers were taken at the 
end of each experiment for freezing at − 80 °C and fixing 
in formalin. During stabilization period and reperfusion, 
the livers were perfused with Krebs–Henseleit buffer (KH 
buffer, 37 °C, pH 7.4), which was previously gassed with 
carbogen (95%  O2 and 5%  CO2, Linde, Unterschleißheim) 
using an oxygenator.
Follow‑Up Study
In this variation of the isolated rat liver perfusion, we 
induced cold liver ischemia in healthy livers of two groups 
of rats (24 h ischemia with or without IPostC 4 × 60 s, each 
n = 4) and collected their reperfusion perfusate, which we 
subsequently used to perfuse a second healthy rat liver (Sup-
plementary Fig-1).
In Vivo Model: Warm Ischemia ± IPostC
Animals were anesthetized with an intraperitoneal injection 
of pentobarbital (1:3 diluted with 0.9% NaCl; 30–50 mg/
kg of body weight) and received a subcutaneous injection 
of buprenorphin (0.05 mg/kg of body weight). The caro-
tis artery was cannulated to continuously monitor arterial 
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blood pressure with a pressure gage (Becton, Dickinson 
and Company, New Jersey). After median laparotomy, the 
left liver lobe (segment VIII) was clamped through the 
vena portae and arteria hepatica, and the abdominal wall 
was closed with 3–0 prolene (Ethicon, Somerville). For the 
control group (n = 8), the clamp was removed after 90 min 
of warm ischemia for 90 min of reperfusion. For the inter-
vention group (n = 8), IPostC for 4 × 60 s was performed 
directly after ischemia with subsequent reperfusion. For the 
sham group, 90 + 90 min perfusion without clamping was 
executed (Fig. 1b). Samples of blood and liver were col-
lected at the end of the experiments and stored at − 80 °C. 
Additional samples of the liver were fixed in formalin.
Histological Evaluation
Pieces of the livers were fixed in 4% buffered formalin, 
dehydrated in graded ethanol, and embedded in paraffin. 
The sections were stained with hematoxylin–eosin (HE) and 
Elastica van Gieson (EvG) and were evaluated regarding 
the following parameters (supplementary Table 1A and 1B): 
inflammation, fat deposition, group necrosis, and fibrosis. 
The graduation of parameters was carried out as follows: 
0 = none, 1 = low, 2 = moderate, and 3 = severe. All steps 
were performed at the Department of Pathology of LMU 
Munich.
Lactate Dehydrogenase
The quantity of LDH in the perfusate was measured using 
an enzymatic test of the kinetic indicator reaction at 365 nm. 
LDH activity is thus proportional to a decrease in NADH. 
After a measurement in the linear range, the concentration 
of LDH (in mU/min x g liver) was calculated.
Enzyme‑Linked Immunosorbent Assay (ELISA)
The efflux of thromboxane  B2 into the perfusate was 
measured with an enzyme-linked immunosorbent assay 
(Cayman Chemical, Ann Arbor). Additionally, concentra-
tions of TNF-α and IL-6 in the serum were quantified by 
enzyme-linked immunosorbent assays (Young In Frontier 
Co., Seoul).
Serum Enzyme Levels
Blood samples were collected after each in vivo experi-
ment. After precipitation and centrifugation for 10 min at 
3000 rpm, the serum was removed and stored at − 80 °C. 
LDH, AST, and ALT were measured in the serum at the 
Institute of Laboratory Medicine of LMU Munich using 
kinetic UV tests at 37 °C in AU 5800 and AU 680 analysis 
systems (Beckman Coulter GmbH, Krefeld).
RNA Extraction and RT‑qPCR
Total RNA was isolated from rat livers using a  miRNeasy® 
Mini Kit (Qiagen GmbH, Hilden) and quantified photometri-
cally at 260 nm. cDNA synthesis was performed with a  RT2 
First Strand Kit (Qiagen, Hilden). RT-qPCR was executed 
using a Custom  RT2 Profiler PCR Array (Qiagen, Hilden) 
and the  RT2 SYBR Green ROX™ qPCR Master Mix (Qia-
gen, Hilden). Gene expression was evaluated relative to the 
Fig. 1  Experimental protocols for animal studies. a Animals received 
a high-fat diet (HFD) over 4  weeks to induce fatty livers. For the 
implementation of cold ischemia, healthy and fatty livers of male SD 
rats were perfused for 30 min followed by storage for 24 h at 4  °C 
and reperfusion at 37 °C for 120 min. Intervention groups of IPostC 
8 × 20  s and 4 × 60  s were performed after ischemia (control and 
interventions, each n = 7–8). b After the induction of fatty livers by 
HFD for 4 weeks, in vivo studies were performed in healthy and fatty 
livers in male SD rats. The left liver lobe was clamped for 90 min at 
37  °C for partial warm ischemia followed by 90 min reperfusion at 
37 °C. The intervention group with IPostC 4 × 60 s after ischemia was 
established, and a sham group underwent 90 + 90 min without clamp-
ing (sham, control, and intervention: n = 8)
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housekeeping genes Actb and B2m. Genes with reference 
sequences are listed in supplementary Table 2.
Statistical Analysis
All data are expressed as the mean ± standard error of the 
mean (SEM). Statistical analyses of the data were performed 
using GraphPad Prism 8.4.0., and a p value < 0.05 was con-
sidered to be statistically significant. Different parameter 
values and applied statistical tests of Figs. 3, 4, 5, and 6 




Healthy livers showed low focal fat deposition after 24 h of 
cold ischemia. Fatty livers showed very low periportal and 
pericentral fibrosis and severe fat deposition. There was no 
inflammation in either liver model, but a granulocyte phago-
cytosis was noted near necrotic hepatocytes in both models. 
Furthermore, precursors of necrosis, single cell necrosis, 
and cytoplasm degeneration with core whitening, but only 
slight core loss were found in healthy and fatty livers. No 
effect of IPostC could be detected due to an inhomogeneous 
histological appearance (Fig. 2a, b).
The experimental in vivo sham group showed low hepat-
ocyte degeneration without core loss or necrosis. After 
90  min, the histological appearance of warm ischemia 
in vivo with or without IPostC (Fig. 2c–f) was very hetero-
geneous with no clear evidence of an effect of IPostC. A 
low-fat deposition and low inflammation with focal peripor-
tal granulocyte infiltrates was detected. Additional confluent 
cytoplasm degeneration with core whitening, but no core 
loss, was observed.
Cell Damage, Organ Function and Portal Pressure
After ischemia and reperfusion, both groups of IPostC 
(8 × 20 s and 4 × 60 s) had reduced total LDH (Fig. 3a) in 
healthy livers without significant increase in the total bile 
flow (Fig. 3d). In the early phase of reperfusion (minute 
0–60), there was no effect on LDH (Fig. 3b); however, bile 
flow was increased (Fig. 3e) by IPostC. In the late phase 
Fig. 2  Histological evaluation of healthy and fatty livers after cold 
ischemia in  situ and warm ischemia in  vivo. To induce fatty livers, 
male SD rats received a high-fat diet over the course of 4  weeks. 
For cold ischemia, healthy (a) and fatty (b) livers were perfused for 
30 min and stored for 24 h at 4 °C followed by 120 min of reperfu-
sion. Interventions with IPostC 8 × 20 s and 4 × 60 s were carried out 
after ischemia (each n = 7–8 for the control group and interventions). 
To perform in vivo studies, healthy (sham—c; ischemia—d) and fatty 
(sham—e; ischemia—f) livers underwent 90 min partial ischemia at 
37 °C followed by 90 min reperfusion. An IPostC intervention group 
4 × 60  s after ischemia and sham group with 90 + 90  min perfusion 
without clamping were established (sham, control, and intervention, 
each n = 8)

































































































































































































































































































































































Fig. 3  Lactate dehydrogenase, bile flow, and portal perfusion pres-
sure in healthy and fatty livers after cold ischemia in  situ± IPostC. 
Fatty livers were induced by a high-fat diet for 4 weeks. After 30 min 
perfusion, healthy and fatty livers were stored for 24  h at 4  °C fol-
lowed by 120  min reperfusion. IPostC 8 × 20  s and 4 × 60  s were 
performed after ischemia (control and interventions, each n = 7–8). 
Lactate dehydrogenase (LDH) was measured in the perfusate and 
is represented as total value (a) and during the early phase (minute 
0–60; b) and the late phase (minute 60–120; c) of reperfusion. Bile 
was collected, and also, the bile flow is shown as total value (d) and 
at the early (e) and late (f) phase of reperfusion. For the portal per-
fusion pressure (g), which was monitored continuously, the value 
at the end of perfusion is displayed. All data are expressed as the 
mean ± SEM. Significances are specified as *p < 0.05, **p < 0.01, 
***p < 0.001, and ****p < 0.0001
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of reperfusion (minute 70–120), LDH (Fig. 3c) was sig-
nificantly decreased and bile flow (Fig. 3f) was improved 
in both liver models and by both groups of IPostC. Portal 
perfusion pressure was reduced at the end of perfusion 
(Fig. 3g) by IPostC only in healthy livers.
Production of Vasoconstrictor  TXB2
Healthy and fatty livers have nearly the same basal val-
ues for  TXB2 in the perfusate (no data shown). After cold 
ischemia ± IPostC, the total  TXB2 (Fig. 4a) was unchanged 
in both liver models. The early phase of reperfusion 
(Fig. 4b) did not affect IPostC; however, in the late phase 
(Fig. 4c),  TXB2 could be significantly decreased in healthy 
and fatty livers.
Serum Enzyme and Cytokine Levels
Transaminases showed strong increases in the serum of 
healthy and fatty livers after 90 min warm ischemia; the 
same result was noted with LDH (Fig. 5a–c). After IPostC 
4 × 60 s, LDH was significantly reduced in healthy livers 
(Fig. 5a–c). TNF-α and IL-6 had very high levels in the 
serum of both liver models after warm ischemia compared 
with the sham group (Fig. 5d, e). After IPostC 4 × 60 s, 
levels significantly decreased, but remained higher than 
in the sham group (Fig. 5d, e).
Gene Expressions
Following warm ischemia in vivo, the genes of Ccl2, IL-10, 
IL-6, Tnf, and Ripk3 were upregulated in healthy and fatty 
(not Tnf) livers (Fig. 6a–d/g). Expressions of IL-6 and Tnf 
could be significantly reduced in healthy livers by IPostC 
4 × 60 s (Fig. 6c, d). In fatty livers, only decreases in Ccl2 
(Fig. 6a) and Ripk3 (Fig. 6g) were significant; however, 
all other genes as well were substantially downregulated 
with IPostC 4 × 60 s. Genes of Casp8 (Fig. 6e) and Ripk1 
(Fig. 6f) had not changed in healthy or fatty livers after warm 
ischemia and IPostC.
Influence of Postconditioned Perfusate (“Follow‑Up 
Study”)
We hypothesized that one of the major protective mecha-
nisms of ischemic postconditioning is the restricted inflow 
following ischemia. To find out this is not only of major 
relevance for the system of ischemic postconditioning, but 
brings also new light into the mechanisms of ischemia reper-
fusion injury. To test this hypothesis, we collected the whole 
perfusate of rat liver perfusion number one with 24 h cold 
ischemia and reperfusion ± IPostC 4 × 60 s and used it to 
perform a second rat liver perfusion in additional healthy 
rat livers for 80 min (supplementary Fig. 1). The maximal 
and total values of LDH (supplementary Fig. 2A-B) were 
substantially lower after perfusions with postconditioned 
























































































































































Fig. 4  Thromboxane  B2 in healthy and fatty livers after cold ischemia 
in situ ± IPostC. After the induction of fatty livers with a high-fat diet 
for 4  weeks, healthy and fatty livers were perfused for 30  min and 
stored for 24  h at 4  °C followed by 120  min of reperfusion. Inter-
ventions of IPostC for 8 × 20  s and 4 × 60  s were performed after 
ischemia (control and interventions, each n = 7–8). The perfusate 
was collected, and thromboxane  B2  (TXB2) was measured using an 
enzyme-linked immunosorbent assay. The values for  TXB2 are shown 
in total (a) and during the early phase (minute 0–60; b) and the late 
phase (minute 60–120; c) of reperfusion. All data are expressed as 
the mean ± SEM, and significances are specified as **p < 0.01 and 
***p < 0.001
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on bile flow (supplementary Fig. 2C-D). The portal per-
fusion pressure (supplementary Fig. 2E) was significantly 
decreased in the postconditioned perfusate group compared 
to the non-postconditioned group.
Discussion
The so-called intervention of ischemic postconditioning 
(IPostC) was tested in this study and showed a protective 
effect in fatty livers for the first time. With an increasing 
number of fatty liver diseases in the near future [16], this 
might be of major importance. In addition, the experiments 
in the present study showed one important and novel aspect 
of ischemia reperfusion injury: The “dosed” reperfusion in 
the setting of IPostC has been shown to be less harmful to 
the livers.
For IPostC, different time courses (8 × 20 s and 4 × 60 s) 
have been tested in the present study. Organ function could 
be improved in both settings without any relevant dif-
ferences regarding cell damage. So, both settings might 
be helpful in clinical use, but longer cycles could have 
the advantage of reduced damage of the vessels due to 
fewer clamp usages. A similar effect of IPostC has been 
observed in healthy livers [8–10, 17], but in the present 
study protective effects of IPostC were shown in fatty liv-
ers for the first time. The cold ischemia time of 24 h used 
in the present study has also been involved in earlier stud-
ies with fatty livers [18–20]. As stated above, to further 
investigate the mechanisms of IPostC we extended our 
perfusion model in the following way: We experimentally 
induced liver ischemia in two groups of rats (24 h cold 
ischemia with or without IPostC 4 × 60 s) and collected 
their reperfusion perfusate, which we subsequently used 













































































































































































Fig. 5  Enzyme and cytokine levels in the serum of healthy and 
fatty livers after warm ischemia in  vivo ± IPostC. In fatty livers, 
in  vivo studies were performed. For the intervention group, IPostC 
4 × 60 s was carried out after ischemia, and the sham group received 
90 + 90 min without clamping (sham, control, and intervention, each 
n = 8). Serum was collected, and AST (a), ALT (b), and lactate dehy-
drogenase (LDH; c) were measured. Additionally, the cytokines 
tumor necrosis factor α (TNF-α; d) and interleukin 6 (IL-6; e) were 
determined. All data are expressed as the mean ± SEM. Significances 
are specified as **p < 0.01, ***p < 0.001, and ****p < 0.0001
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postconditioned group had substantially reduced damage 
potential compared with the perfusate derived from the 
non-postconditioned group. Therefore, we speculate that 
IPostC reduces the release of liver-damaging metabolites 
into the perfusate, thereby preventing cell damage by IRI. 
Reductions in damaging metabolites could be accom-
plished by previously described cumulative triggers fol-
lowing metabolites as well as end effectors due to IPostC.
Among NO and endothelin, an important mediator in 
disturbed microcirculation during ischemia is the vasocon-
strictor  TXA2 [1, 2]. Additionally,  TXA2 promotes inflam-
matory processes by increasing the expression of adhesion 
molecules [21]. By IPostC  TXB2, the inactive metabolite 
of  TXA2 was reduced in the perfusate after ischemia and 
reperfusion. Thus, IPostC attenuates the production of the 
vasoconstrictor  TXA2, thereby improving microcircula-
tion in liver sinusoids required for the optimal supply of 
hepatocytes with oxygen and nutrients. This aspect is very 
important for fatty livers because fat depositions in the cyto-
plasm of hepatocytes cause an increased cell volume, which 
restricts the sinusoidal space prior to ischemia and reperfu-
sion and worsens microcirculation [17].
To evaluate IPostC effect further, in vivo experiments 
were performed in healthy and fatty livers. Hepatic transami-
nases (ALT and AST) and LDH increased after 90 min of 
warm ischemia and were reduced by IPostC (LDH signifi-
cantly in healthy livers), thereby confirming the protective 
effect of IPostC on healthy and fatty livers in vivo. Due to 
their clinical relevance, many experimental studies previ-
ously described a positive effect for IPostC on AST and 
ALT [9, 13, 22–24]. Additionally, two relevant cytokines 
in the genesis of IRI (TNF-α and IL-6) were measured in 
the serum. TNF-α was significantly decreased by IPostC in 
healthy as well as in fatty livers, IL-6 only in healthy liv-
ers. This is in accordance to previous studies which found 
reduced TNF-α in the serum [25] and liver tissue [17, 26]. 
IL-6 has been described in one study before on remote 
ischemic postconditioning (RIPostC) in an LPS-induced sys-
temic inflammation model. A reduction in IL-6 and TNF-α 
in the serum due to RIPostC was found [27], which indicates 
a protective effect of IPostC even if performed indirectly.
To understand the underlying molecular mechanisms 
of IPostC in vivo after warm ischemia, we examined the 
expression of genes under the hypothesis to be involved in 









































































































































































































































































































D E F G
Fig. 6  Gene expressions in healthy and fatty livers after warm 
ischemia in vivo ± IPostC. The gene expressions of Ccl2 (a), interleu-
kin 10 (IL-10; b), interleukin 6 (IL-6; c), tumor necrosis factor (Tnf; 
d), Caspase 8 (Casp8; e), receptor-interacting protein kinase (Ripk1; 
F), and receptor-interacting protein kinase 3 (Ripk3; g) were investi-
gated using RT-qPCR. The gene expressions of intervention groups 
(control and 4 × 60  s) are represented as the fold change compared 
with the sham group (mean ± SEM; each n = 8). Significances are 
specified as *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001
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a lower accumulation and activation of immune cells by 
IPostC. The first investigated chemokine Ccl2 is released 
from KCs. It is known to damage hepatocytes and activate 
hepatic stellate cells (HSCs) and interestingly was described 
as upregulated chemokine in fatty livers [28]. The reduced 
expression of Ccl2 in fatty livers by IPostC confirmed the 
inflammatory hypothesis and indicates an attenuated infiltra-
tion of immunologically active cells into the tissue as well 
as a reduction in cellular damage. Ccl2 has not been inves-
tigated regarding its role in inhibiting IRI in an IPostC sce-
nario in the liver; however, ICAM 1, an adhesion molecule 
involved in recruiting neutrophils, was shown to be immu-
nohistochemically reduced in liver tissue by IPostC [26].
In addition to ischemic postconditioning, also ischemic 
preconditioning and ischemic remote postconditioning 
have been investigated in experimental and human studies 
[29–33]. Possible mechanisms among others were related to 
adenosine, NO, or cytokines [34–37]. To compare the effects 
and mechanisms of all three variants was out of the scope of 
the present study, but might be focused on further studies in 
fatty livers. Overall ischemic postconditioning can be per-
formed after the transplantation in the transplant center. This 
has the advantage of easier logistics, but the differences in 
effects are not yet known. Remote ischemic postconditioning 
could also be performed in the transplant center, but needs 
additional trauma. Therefore, ischemic postconditioning 
might be a simple and easy-to-perform procedure to improve 
outcome after liver transplantation, but studies in humans 
will be needed.
These novel findings might have impact on future surgi-
cal procedures in the setting of liver transplantation or liver 
resection as there is a wide range how to dose inflow into 
the liver following ischemia. One possibility is the additional 
off and on clamping of the portal vein as it is proposed here 
(IPostC). On the other hand, also a slowly opening of the 
clamp might be feasible, but has not been investigated in 
the present study.
In summary (see also Fig. 7), IPostC offers a very promis-
ing method to protect healthy and fatty livers from IRI. The 
idea of “dosed” reperfusion might have impact for future 
treatment. We could show in complex follow-up experiments 
that the medium of a postconditioned liver has lower poten-
tial to damage a second liver. From a clinical point of view, 
the intervention of ischemic postconditioning may help to 
improve graft function after ischemia reperfusion injury.
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